MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-19-2025
OpGen Market Cap 2011-2026 | OPGN
As of April 27, 2026 OpGen has a market cap of $ 1.54 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap OpGen
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.12 M | 2 M | 374 K | 1.61 M | 34.3 M | 2.46 M | 9.01 M | 7.87 M | 20.8 M | 11.3 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 34.3 M | 374 K | 9.89 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Diagnostics research industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
221 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
42 B | $ 116.17 | 0.54 % | $ 35.3 B |  USA |
|
Akumin
AKU
|
75.1 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
40.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
16.4 B | $ 128.13 | 0.2 % | $ 20.4 B | USA |
 |
Co-Diagnostics
CODX
|
5.85 M | $ 1.67 | - | $ 2.22 M | USA |
 |
Aspira Women's Health
AWH
|
45.4 M | - | -6.19 % | $ 10.5 M | USA |
 |
Lantheus Holdings
LNTH
|
5.12 B | $ 84.55 | 0.26 % | $ 5.71 B | USA |
 |
Medpace Holdings
MEDP
|
13 B | $ 416.87 | 1.54 % | $ 12 B | USA |
 |
Biocept
BIOC
|
5.93 M | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
709 M | $ 25.33 | 3.56 % | $ 704 M | USA |
 |
Chembio Diagnostics
CEMI
|
12.6 M | - | 0.22 % | $ 16.8 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
30.8 B | $ 27.56 | 0.33 % | $ 20 B |  Niderland |
 |
Check-Cap Ltd.
CHEK
|
4.33 M | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
993 M | $ 21.59 | 1.7 % | $ 1.15 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
421 M | - | - | $ 562 M |  Britain |
 |
Senseonics Holdings
SENS
|
351 M | $ 7.13 | 1.13 % | $ 298 M | USA |
 |
Soleno Therapeutics
SLNO
|
2.08 B | $ 52.73 | 0.01 % | $ 2.68 B | USA |
 |
DermTech
DMTK
|
42.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
57.5 K | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
19.5 B | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
467 M | $ 16.0 | -1.9 % | $ 484 M | USA |
 |
Thermo Fisher Scientific
TMO
|
196 B | $ 468.52 | -0.22 % | $ 177 B | USA |
 |
Global Cord Blood Corporation
CO
|
243 M | - | - | $ 399 M |  China |
 |
Trinity Biotech plc
TRIB
|
120 M | $ 0.64 | -1.51 % | $ 61.9 M |  Irlanda |
 |
Fluidigm Corporation
FLDM
|
481 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.54 B | - | 0.12 % | $ 80.1 M | China |
 |
Twist Bioscience Corporation
TWST
|
1.56 B | $ 60.4 | -0.89 % | $ 3.61 B | USA |
 |
Charles River Laboratories International
CRL
|
7.69 B | $ 172.02 | 1.33 % | $ 8.53 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
7.87 B | - | - | $ 10.7 B | USA |
 |
Guardant Health
GH
|
13.4 B | $ 90.04 | 1.27 % | $ 11.3 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
2.99 M | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
844 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
7.34 M | $ 1.91 | -3.29 % | $ 8.45 M | USA |
 |
Motus GI Holdings
MOTS
|
990 K | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
8.52 B | - | - | $ 10.6 B | Niderland |
 |
Neogen Corporation
NEOG
|
1.02 B | $ 9.51 | -0.37 % | $ 2.06 B | USA |
 |
Biomerica
BMRA
|
7.19 M | $ 2.16 | 0.86 % | $ 4.96 M | USA |
 |
National Research Corporation
NRC
|
315 M | $ 17.09 | -0.81 % | $ 383 M | USA |
 |
ICON Public Limited Company
ICLR
|
16.6 B | $ 100.76 | -1.38 % | $ 8.31 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
23.9 B | $ 263.91 | 0.06 % | $ 22 B | USA |
 |
Celcuity
CELC
|
5.37 B | $ 122.87 | 1.52 % | $ 5.75 B | USA |
 |
NeoGenomics
NEO
|
1.48 B | $ 8.6 | 3.68 % | $ 1.1 B | USA |
 |
Myriad Genetics
MYGN
|
409 M | $ 4.76 | -0.31 % | $ 441 M | USA |
 |
Natera
NTRA
|
5.31 B | $ 205.87 | 1.04 % | $ 20.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
23.3 B | $ 196.59 | 0.19 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
511 M | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
14.1 B | - | -0.91 % | $ 14.7 B | USA |